Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TuberQ: a Mycobacterium tuberculosis protein druggability database

8 May 2014

Abstract excerpt

In 2012 an estimated 8.6 million people developed tuberculosis (TB) and 1.3 million died from the disease [including 320 000 deaths among human immunodeficiency virus (HIV)-positive people]. There is an urgent need for new anti-TB drugs owing to the following: the fact that current treatments have severe side effects, the increasing emergence of multidrug-resistant strains of Mycobacterium tuberculosis (Mtb), the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Tuberculosis Research and Epidemiology
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24816183
DOI: 10.1093/database/bau035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TuberQ: a Mycobacterium tuberculosis protein druggability databasePMID 24816183Read ↗

Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosisSemantic proximity Read ↗

The Mycobacterium tuberculosis Drugome and Its Polypharmacological ImplicationsSemantic proximity Read ↗

Target Identification in Anti-Tuberculosis Drug DiscoverySemantic proximity Read ↗

targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysisSemantic proximity Read ↗

Identification and Validation of Novel Drug Targets in TuberculosisSemantic proximity Read ↗

Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosisSemantic proximity Read ↗

PBITV3 : A robust and comprehensive tool for screening pathogenic proteomes for drug targets and prioritizing vaccine candidatesSemantic proximity Read ↗

In Silico Strategies in Tuberculosis Drug DiscoverySemantic proximity Read ↗

TB database: an integrated platform for tuberculosis researchSemantic proximity Read ↗

Structural Annotation of Mycobacterium tuberculosis ProteomeSemantic proximity Read ↗

Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosisSemantic proximity Read ↗

HANSEN: An Integrated Structural and Functional Proteome Resource for Structure-Guided Drug Discovery in <i>Mycobacterium leprae</i>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.